OACC
Oaktree Acquisition Corp. III Life Sciences
Shell Companies
Market Cap$261M
5Y Perf.+6.5%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
OACC vs IQV
Revenue, margins, valuation, and 5-year total return — side by side.
IQV
IQVIA Holdings Inc.
Medical - Diagnostics & Research
Market Cap$30.32B
5Y Perf.-9.1%
OACC vs IQV — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | OACC | IQV |
|---|---|---|
| Industry | Shell Companies | Medical - Diagnostics & Research |
| Market Cap | $261M | $30.32B |
| Revenue (TTM) | $0.00 | $16.63B |
| Net Income (TTM) | $5M | $1.39B |
| Gross Margin | — | 26.1% |
| Operating Margin | — | 13.9% |
| Forward P/E | 195.8x | 14.1x |
| Total Debt | $12K | $16.17B |
| Cash & Equiv. | $1M | $1.98B |
OACC vs IQV — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
OACC
IQV
| Stock | Dec 24 | May 26 | Return |
|---|---|---|---|
| Oaktree Acquisition… (OACC) | 100 | 106.5 | +6.5% |
| IQVIA Holdings Inc. (IQV) | 100 | 90.9 | -9.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: OACC vs IQV
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: IQV leads in 4 of 6 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Oaktree Acquisition Corp. III Life Sciences is the stronger pick specifically for capital preservation and lower volatility. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
OACC
Oaktree Acquisition Corp. III Life Sciences
The Banking Pick
OACC is the clearest fit if your priority is income & stability and sleep-well-at-night.
- beta 0.08
- Lower volatility, beta 0.08, Low D/E 0.0%, current ratio 2.14x
- Beta 0.08, current ratio 2.14x
Best for: income & stability and sleep-well-at-night
IQV
IQVIA Holdings Inc.
The Long-Run Compounder
IQV carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 166.5% 10Y total return vs OACC's 6.1%
- Lower P/E (14.1x vs 195.8x)
- 8.3% margin vs OACC's 0.8%
Best for: long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Value | IQV | Lower P/E (14.1x vs 195.8x) |
| Quality / Margins | IQV | 8.3% margin vs OACC's 0.8% |
| Stability / Safety | OACC | Beta 0.08 vs IQV's 1.33, lower leverage |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | IQV | +16.5% vs OACC's +1.4% |
| Efficiency (ROA) | IQV | 4.7% ROA vs OACC's 2.6% |
OACC vs IQV — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FY 2025
OACC vs IQV — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLOACCLAGGINGIQV
IQVIQVIA Holdings Inc.
1leads
OACCOaktree Acquisition C…
2leads
6 Total Categories
CATEGORYLEADERvs IQVMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
—
—
Valuation MetricsMultiples, price ratios, and targets
IQV2/3
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
Tied
—
Total Returns1Y, 3Y, 5Y total returns with dividends
OACC4/6
Risk & VolatilityBeta, volatility, and downside exposure
OACC2/2
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
Insufficient data to determine a leader in this category.
Income & Cash Flow (Last 12 Months)
IQV and OACC operate at a comparable scale, with $16.6B and $0 in trailing revenue.
| Metric | OACCOaktree Acquisiti… | IQVIQVIA Holdings In… |
|---|---|---|
| RevenueTrailing 12 months | $0 | $16.6B |
| EBITDAEarnings before interest/tax | -$847,195 | $3.5B |
| Net IncomeAfter-tax profit | $5M | $1.4B |
| Free Cash FlowCash after capex | -$278,200 | $2.7B |
| Gross MarginGross profit ÷ Revenue | — | +26.1% |
| Operating MarginEBIT ÷ Revenue | — | +13.9% |
| Net MarginNet income ÷ Revenue | — | +8.3% |
| FCF MarginFCF ÷ Revenue | — | +16.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +8.4% |
| EPS Growth (YoY)Latest quarter vs prior year | — | +15.0% |
Insufficient data to determine a leader in this category.
Valuation Metrics
IQV leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
At 22.8x trailing earnings, IQV trades at a 88% valuation discount to OACC's 195.8x P/E. On an enterprise value basis, IQV's 13.0x EV/EBITDA is more attractive than OACC's 9999.0x.
| Metric | OACCOaktree Acquisiti… | IQVIQVIA Holdings In… |
|---|---|---|
| Market CapShares × price | $261M | $30.3B |
| Enterprise ValueMkt cap + debt − cash | $259M | $44.5B |
| Trailing P/EPrice ÷ TTM EPS | 195.76x | 22.79x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 14.06x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.56x |
| EV / EBITDAEnterprise value multiple | 9999.00x | 12.97x |
| Price / SalesMarket cap ÷ Revenue | — | 1.86x |
| Price / BookPrice ÷ Book value/share | 1.39x | 4.67x |
| Price / FCFMarket cap ÷ FCF | — | 14.78x |
IQV leads this category, winning 2 of 3 comparable metrics.
Profitability & Efficiency
Evenly matched — OACC and IQV each lead in 3 of 6 comparable metrics.
Profitability & Efficiency
IQV delivers a 22.1% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $0 for OACC. OACC carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to IQV's 2.44x.
| Metric | OACCOaktree Acquisiti… | IQVIQVIA Holdings In… |
|---|---|---|
| ROE (TTM)Return on equity | +0.0% | +22.1% |
| ROA (TTM)Return on assets | +2.6% | +4.7% |
| ROICReturn on invested capital | — | +8.7% |
| ROCEReturn on capital employed | -0.0% | +11.0% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 |
| Debt / EquityFinancial leverage | 0.00x | 2.44x |
| Net DebtTotal debt minus cash | -$1M | $14.2B |
| Cash & Equiv.Liquid assets | $1M | $2.0B |
| Total DebtShort + long-term debt | $11,824 | $16.2B |
| Interest CoverageEBIT ÷ Interest expense | — | 3.10x |
Evenly matched — OACC and IQV each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
OACC leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in OACC five years ago would be worth $10,610 today (with dividends reinvested), compared to $7,621 for IQV. Over the past 12 months, IQV leads with a +16.5% total return vs OACC's +1.4%. The 3-year compound annual growth rate (CAGR) favors OACC at 2.0% vs IQV's -2.0% — a key indicator of consistent wealth creation.
| Metric | OACCOaktree Acquisiti… | IQVIQVIA Holdings In… |
|---|---|---|
| YTD ReturnYear-to-date | -0.0% | -20.7% |
| 1-Year ReturnPast 12 months | +1.4% | +16.5% |
| 3-Year ReturnCumulative with dividends | +6.1% | -5.9% |
| 5-Year ReturnCumulative with dividends | +6.1% | -23.8% |
| 10-Year ReturnCumulative with dividends | +6.1% | +166.5% |
| CAGR (3Y)Annualised 3-year return | +2.0% | -2.0% |
OACC leads this category, winning 4 of 6 comparable metrics.
Risk & Volatility
OACC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
OACC is the less volatile stock with a 0.08 beta — it tends to amplify market swings less than IQV's 1.33 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. OACC currently trades 98.8% from its 52-week high vs IQV's 72.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | OACCOaktree Acquisiti… | IQVIQVIA Holdings In… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.08x | 1.33x |
| 52-Week HighHighest price in past year | $10.74 | $247.05 |
| 52-Week LowLowest price in past year | $10.30 | $134.65 |
| % of 52W HighCurrent price vs 52-week peak | +98.8% | +72.3% |
| RSI (14)Momentum oscillator 0–100 | 47.6 | 58.5 |
| Avg Volume (50D)Average daily shares traded | 38K | 1.6M |
OACC leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | OACCOaktree Acquisiti… | IQVIQVIA Holdings In… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $225.63 |
| # AnalystsCovering analysts | — | 44 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 2 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +4.1% |
Insufficient data to determine a leader in this category.
Key Takeaway
OACC leads in 2 of 6 categories (Total Returns, Risk & Volatility). IQV leads in 1 (Valuation Metrics). 1 tied.
Best OverallOaktree Acquisition Corp. I… (OACC)Leads 2 of 6 categories
Loading custom metrics...
OACC vs IQV: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is OACC or IQV a better buy right now?
IQVIA Holdings Inc.
(IQV) offers the better valuation at 22. 8x trailing P/E (14. 1x forward), making it the more compelling value choice. Analysts rate IQVIA Holdings Inc. (IQV) a "Buy" — based on 44 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — OACC or IQV?
On trailing P/E, IQVIA Holdings Inc.
(IQV) is the cheapest at 22. 8x versus Oaktree Acquisition Corp. III Life Sciences at 195. 8x.
03Which is the better long-term investment — OACC or IQV?
Over the past 5 years, Oaktree Acquisition Corp.
III Life Sciences (OACC) delivered a total return of +6. 1%, compared to -23. 8% for IQVIA Holdings Inc. (IQV). Over 10 years, the gap is even starker: IQV returned +166. 5% versus OACC's +6. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — OACC or IQV?
By beta (market sensitivity over 5 years), Oaktree Acquisition Corp.
III Life Sciences (OACC) is the lower-risk stock at 0. 08β versus IQVIA Holdings Inc. 's 1. 33β — meaning IQV is approximately 1543% more volatile than OACC relative to the S&P 500. On balance sheet safety, Oaktree Acquisition Corp. III Life Sciences (OACC) carries a lower debt/equity ratio of 0% versus 2% for IQVIA Holdings Inc. — giving it more financial flexibility in a downturn.
05Which has better profit margins — OACC or IQV?
IQVIA Holdings Inc.
(IQV) is the more profitable company, earning 8. 3% net margin versus 0. 0% for Oaktree Acquisition Corp. III Life Sciences — meaning it keeps 8. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IQV leads at 14. 0% versus 0. 0% for OACC. At the gross margin level — before operating expenses — IQV leads at 26. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — OACC or IQV?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is OACC or IQV better for a retirement portfolio?
For long-horizon retirement investors, Oaktree Acquisition Corp.
III Life Sciences (OACC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 08)). Both have compounded well over 10 years (OACC: +6. 1%, IQV: +166. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between OACC and IQV?
These companies operate in different sectors (OACC (Financial Services) and IQV (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
P/E Ratio<
x
(OACC: 195.8x · IQV: 22.8x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.